Water tower research publishes initiation of coverage report on cybin, inc., “a leader in novel neuropsychiatry therapeutics”

Water tower research has published an initiation of coverage report on cybin, inc. (nyse am: cybn) titled, “a leader in novel neuropsychiatry therapeutics”. water tower research has published an initiation of coverage report on cybin, inc. (nyse am: cybn) titled, “a leader in novel neuropsychiatry therapeutics”.
CYBN Ratings Summary
CYBN Quant Ranking